{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T16:45:10Z","timestamp":1758991510370,"version":"3.44.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1016\/j.jinf.2005.10.011","type":"journal-article","created":{"date-parts":[[2005,11,29]],"date-time":"2005-11-29T07:42:00Z","timestamp":1133250120000},"page":"e79-e82","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Immune reconstitution syndrome associated with parvovirus B19-induced pure red cell aplasia during highly active antiretroviral therapy"],"prefix":"10.1016","volume":"53","author":[{"given":"Poj","family":"Intalapaporn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Poovorawan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chusana","family":"Suankratay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2005.10.011_bib1","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1056\/NEJMra030840","article-title":"Parvovirus B19","volume":"350","author":"Young","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2005.10.011_bib2","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1128\/CMR.15.3.485-505.2002","article-title":"Human parvovirus B19","volume":"15","author":"Heegaard","year":"2002","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jinf.2005.10.011_bib3","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0733-8635(01)00013-4","article-title":"Parvovirus B19: a review","volume":"20","author":"Katta","year":"2002","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jinf.2005.10.011_bib4","first-page":"208","article-title":"Hematologic manifestations of the human immune deficiency virus (HIV)","volume":"25","author":"Zon","year":"1988","journal-title":"Semin Hematol"},{"key":"10.1016\/j.jinf.2005.10.011_bib5","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/clinids\/23.6.1255","article-title":"Prevalence of parvovirus B19 infection in patients infected with human immunodeficiency virus","volume":"23","author":"van Elsacker-Niele","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2005.10.011_bib6","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/clinids\/20.1.170","article-title":"Infection due to parvovirus B19 in patients infected with human immunodeficiency virus","volume":"20","author":"Chernak","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2005.10.011_bib7","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/00005792-200205000-00005","article-title":"Immune reconstitution syndrome. Emergence of a unique syndrome during highly active antiretroviral therapy","volume":"81","author":"Shelburne","year":"2002","journal-title":"Medicine"},{"key":"10.1016\/j.jinf.2005.10.011_bib8","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1086\/383034","article-title":"Immune reconstitution in HIV-infected patients","volume":"38","author":"Hirsch","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2005.10.011_bib9","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1097\/00002030-199211000-00009","article-title":"Zidovudine-induced restoration of cell-mediated immunity to mycobacterium in immunodeficient HIV-infected patients","volume":"6","author":"French","year":"1992","journal-title":"AIDS"},{"key":"10.1016\/j.jinf.2005.10.011_bib10","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1086\/374603","article-title":"Parvovirus B19 encephalitis presenting as immune restoration disease after highly active antiretroviral therapy for human immunodeficiency virus infection","volume":"36","author":"Nolan","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2005.10.011_bib11","first-page":"4031","article-title":"The pathophysiology of pure red cell aplasia: implications for therapy","volume":"11","author":"Charles","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.jinf.2005.10.011_bib12","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1097\/00002030-199908200-00023","article-title":"Reversible zidovudine-induced pure red cell aplasia","volume":"13","author":"Blanche","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/j.jinf.2005.10.011_bib13","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s002770050340","article-title":"Pathogenesis and pathophysiology of anemia in HIV infection","volume":"75","author":"Kreuzer","year":"1997","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jinf.2005.10.011_bib14","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/1096-8652(200011)65:3<189::AID-AJH2>3.0.CO;2-6","article-title":"Lamivudine-induced pure red cell aplasia","volume":"65","author":"Majluf-Cruz","year":"2000","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jinf.2005.10.011_bib15","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1007\/BF01709261","article-title":"Low prevalence of active parvovirus B19 infection in HIV-infected patients","volume":"16","author":"Raguin","year":"1997","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jinf.2005.10.011_bib16","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0046-8177(97)90146-5","article-title":"Human parvovirus B19 in bone marrows from adults with acquired immunodeficiency syndrome: a comparative study using in situ hybridization and immuno-histochemistry","volume":"28","author":"Liu","year":"1997","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jinf.2005.10.011_bib17","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0046-8177(00)80215-4","article-title":"Unusual bone marrow manifestations of parvovirus B19 infection in immunocompromised patients","volume":"31","author":"Crook","year":"2000","journal-title":"Human Pathol"},{"key":"10.1016\/j.jinf.2005.10.011_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcv.2004.05.001","article-title":"Detection and quantitation of parvovirus B19","volume":"31","author":"Brown","year":"2004","journal-title":"J Clin Virol"},{"issue":"Suppl. 1","key":"10.1016\/j.jinf.2005.10.011_bib19","first-page":"16","article-title":"Parvovirus infection and its treatment","volume":"104","author":"Young","year":"1996","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jinf.2005.10.011_bib20","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/(SICI)1096-8652(199905)61:1<16::AID-AJH4>3.0.CO;2-Y","article-title":"Chronic pure red cell aplasia caused by parvovirus B19 in AIDS: use of intravenous immunoglobulin \u2013 a report of eight patients","volume":"61","author":"Koduri","year":"1999","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jinf.2005.10.011_bib21","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1365-2141.1995.tb05250.x","article-title":"Management of persistent B19 parvovirus infection in AIDS","volume":"91","author":"Ramratnam","year":"1995","journal-title":"Br J Hematol"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445305003269?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445305003269?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T15:29:52Z","timestamp":1758986992000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445305003269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["S0163445305003269"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2005.10.011","relation":{},"ISSN":["0163-4453"],"issn-type":[{"type":"print","value":"0163-4453"}],"subject":[],"published":{"date-parts":[[2006,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune reconstitution syndrome associated with parvovirus B19-induced pure red cell aplasia during highly active antiretroviral therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2005.10.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 The British Infection Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}